These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33678606)

  • 21. Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma.
    Goedegebuure RSA; Harrasser M; de Klerk LK; van Schooten TS; van Grieken NCT; Eken M; Grifhorst MS; Pocorni N; Jordanova ES; van Berge Henegouwen MI; Pouw RE; Verheul HMW; van der Vliet JJ; van Laarhoven HWM; Thijssen VLJL; Bass AJ; De Gruijl TD; Derks S
    Oncoimmunology; 2021; 10(1):1954807. PubMed ID: 34377591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of tumour microenvironment-related genes by TCGA database in rectal cancer.
    Li C; Liu T; Liu Y; Zhang J; Zuo D
    J Cell Mol Med; 2021 Jun; 25(12):5811-5822. PubMed ID: 33949771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Global DNA methylation is altered by neoadjuvant chemoradiotherapy in rectal cancer and may predict response to treatment - A pilot study.
    Tsang JS; Vencken S; Sharaf O; Leen E; Kay EW; McNamara DA; Deasy J; Mulligan ED
    Eur J Surg Oncol; 2014 Nov; 40(11):1459-66. PubMed ID: 25108814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comprehensive evaluation of the effectiveness of gene expression signatures to predict complete response to neoadjuvant chemoradiotherapy and guide surgical intervention in rectal cancer.
    Lopes-Ramos C; Koyama FC; Habr-Gama A; Salim AC; Bettoni F; Asprino PF; França GS; Gama-Rodrigues J; Parmigiani RB; Perez RO; Galante PA; Camargo AA
    Cancer Genet; 2015 Jun; 208(6):319-26. PubMed ID: 25963525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.
    McCoy MJ; Hemmings C; Anyaegbu CC; Austin SJ; Lee-Pullen TF; Miller TJ; Bulsara MK; Zeps N; Nowak AK; Lake RA; Platell CF
    Oncotarget; 2017 Mar; 8(12):19803-19813. PubMed ID: 28177891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNA expressions in rectal cancer as predictors of response to neoadjuvant chemoradiation therapy.
    Kheirelseid EA; Miller N; Chang KH; Curran C; Hennessey E; Sheehan M; Newell J; Lemetre C; Balls G; Kerin MJ
    Int J Colorectal Dis; 2013 Feb; 28(2):247-60. PubMed ID: 22903298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy.
    Sun W; Li G; Wan J; Zhu J; Shen W; Zhang Z
    Oncotarget; 2016 Oct; 7(43):69507-69517. PubMed ID: 27486758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
    Yu SK; Tait D; Chau I; Brown G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis.
    Croner RS; Sevim M; Metodiev MV; Jo P; Ghadimi M; Schellerer V; Brunner M; Geppert C; Rau T; Stürzl M; Naschberger E; Matzel KE; Hohenberger W; Lottspeich F; Kellermann J
    Int J Mol Sci; 2016 Feb; 17(2):209. PubMed ID: 26861291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 53BP1 expression and immunoscore are associated with the efficacy of neoadjuvant chemoradiotherapy for rectal cancer.
    Huang A; Xiao Y; Peng C; Liu T; Lin Z; Yang Q; Zhang T; Liu J; Ma H
    Strahlenther Onkol; 2020 May; 196(5):465-473. PubMed ID: 31828392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-Infiltrating PD-1+ Immune Cell Density is Associated with Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Kitagawa Y; Akiyoshi T; Yamamoto N; Mukai T; Hiyoshi Y; Yamaguchi T; Nagasaki T; Fukunaga Y; Hirota T; Noda T; Kawachi H
    Clin Colorectal Cancer; 2022 Mar; 21(1):e1-e11. PubMed ID: 35123891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of response to preoperative chemoradiotherapy in rectal cancer by using reverse transcriptase polymerase chain reaction analysis of four genes.
    Watanabe T; Kobunai T; Akiyoshi T; Matsuda K; Ishihara S; Nozawa K
    Dis Colon Rectum; 2014 Jan; 57(1):23-31. PubMed ID: 24316942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
    Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
    Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma.
    Farchoukh L; Hartman DJ; Ma C; Celebrezze J; Medich D; Bahary N; Frank M; Pantanowitz L; Pai RK
    Mod Pathol; 2021 Jan; 34(1):171-183. PubMed ID: 32661298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting multi-class responses to preoperative chemoradiotherapy in rectal cancer patients.
    Gim J; Cho YB; Hong HK; Kim HC; Yun SH; Wu HG; Jeong SY; Joung JG; Park T; Park WY; Lee WY
    Radiat Oncol; 2016 Mar; 11():50. PubMed ID: 27005571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
    Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
    Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiles of tumor regression grade in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Matsushita K; Kawamura M; Okugawa Y; Hiro J; Inoue Y; Uchida K; Mohri Y; Kusunoki M
    Oncol Rep; 2012 Sep; 28(3):855-61. PubMed ID: 22711167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis].
    Wang XJ; Yu Q; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1183-1187. PubMed ID: 31874536
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.